Optima Medical Innovations Corp.
TOKIF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $1 | $0 |
| % Growth | -16% | 690.8% | 97,772% | – |
| Cost of Goods Sold | $3 | $10 | $7 | $0 |
| Gross Profit | $1 | -$4 | -$6 | $0 |
| % Margin | 29.9% | -76.1% | -844.5% | 63.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $7 | $8 | $0 |
| SG&A Expenses | $3 | $3 | $1 | $0 |
| Sales & Mktg Exp. | $0 | -$4 | -$6 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $2 | $0 |
| Operating Income | -$2 | -$7 | -$7 | -$0 |
| % Margin | -34.6% | -129.2% | -1,064.4% | -790.9% |
| Other Income/Exp. Net | -$2 | -$10 | -$7 | -$0 |
| Pre-Tax Income | -$4 | -$18 | -$14 | -$0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$4 | -$18 | -$15 | -$0 |
| % Margin | -85.9% | -328.3% | -2,144.6% | -19,377.7% |
| EPS | -0.016 | -0.42 | -1.04 | -0.001 |
| % Growth | 96.2% | 59.6% | -86,566.7% | – |
| EPS Diluted | -0.016 | -0.42 | -1.04 | -0.001 |
| Weighted Avg Shares Out | 243 | 43 | 14 | 117 |
| Weighted Avg Shares Out Dil | 243 | 43 | 14 | 117 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$3 | -$16 | -$14 | -$0 |
| % Margin | -62.7% | -299.6% | -1,984.5% | -18,984.6% |